The offering is tiny in absolute dollars but massive in dilution, indicating acute cash constraints. Watch for further equity issuances or debt covenant breaches; the use of proceeds for debt restructuring suggests financial distress.
Price Chart
Executive Summary
NewGenIVF closed a public offering raising ~$1.25M at $0.07/share, issuing 17.86M shares/pre-funded warrants. The tiny raise and massive dilution (likely >100% of outstanding) signal severe cash needs for debt restructuring and Nodexus deployment, reinforcing the bearish trajectory seen in prior filings.
Key Financial Metrics
Key Facts
- Gross proceeds of ~$1.25 million from a public offering of 17,857,143 Class A Ordinary Shares or pre-funded warrants.
- Offering price of $0.07 per share / $0.06999 per pre-funded warrant.
- Proceeds to be used for investment in K25.ai, debt restructuring, working capital, and manufacturing/deployment of Nodexus machines.
- Aegis Capital Corp. acted as exclusive placement agent.
- Registration statement on Form F-1 (No. 333-298442) declared effective September 28, 2026; offering closed September 30, 2026.
Financial Impact
~$1.25M gross proceeds with extreme dilution — 17.86M shares at $0.07 each, likely exceeding 100% of pre-offering shares outstanding.
Risk Factors
- Extreme shareholder dilution from 17.86M new shares at a low $0.07 price.
- Proceeds used for debt restructuring and working capital, signaling potential liquidity stress.
- Multiple business lines (real estate, digital assets, IVF) with uncertain cash generation ability.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3372332 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 6-K | $0.1884 $0.1489 | ▼ −20.97% | ▼ −19.79% | $1.46 (+674.95%) |
Oct 7, 2026 19d ago | 6-K | $0.0811 $0.0721 | ▲ +11.10% | ▲ +11.70% | $1.46 (−1700.25%) |
Oct 7, 2026 19d ago | 6-K | $0.1060 $0.0811 | ▼ −23.49% | ▼ −23.07% | $1.46 (+1277.36%) |
Oct 6, 2026 20d ago | SC 13D/A | $0.0987 $0.1060 | ▲ +7.40% | ▲ +7.64% | $1.46 (+1379.23%) |
Oct 5, 2026 21d ago | 6-K | $0.1100 $0.0987 | ▲ +10.27% | ▲ +10.82% | $1.46 (−1227.27%) |
Sep 30, 2026 26d ago | Press Release | $0.1680 $0.1010 | ▲ +39.88% | ▲ +40.06% | $1.46 (−769.05%) |
Sep 30, 2026 26d ago | 424B4 | $5.38 $3.23 | ▲ +39.88% | ▲ +40.06% | $1.46 (+72.84%) |
Sep 29, 2026 27d ago | EFFECT | $0.0720 $0.1680 | ▼ −133.33% | ▼ −133.54% | $1.46 (−1927.78%) |
Sep 28, 2026 27d ago | Press Release | $0.0720 $0.1680 | ▼ −133.33% | ▼ −133.54% | $1.46 (−1927.78%) |
Sep 2, 2026 7w ago | Insider Cluster | $1.21 $1.18 | ▼ −2.48% | ▼ −3.53% | $1.46 (+20.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers